Stocks are struggling as money streams away from U.S. assets.
Call toll-free 800.328.1267
Stocks are struggling as money streams away from U.S. assets.
Biotech stocks have been the poster child of relative strength in recent weeks. Relative strength (not to be confused with the Relative Strength Index) measures the performance of a stock or index against a broader benchmark like the S&P 500 index ($SPX.X). Though...
A lot of catalysts are vying for attention after last week's sharp drop, but two earlier trends seem to remain intact. First, health-care stocks enjoyed surprising positive results last earnings season. That made the SPDR Health Care ETF (XLV) the best-performing...